What is Eikon Therapeutics, Inc. 's other operating expenses?

Eikon Therapeutics, Inc. (EIKN) reported other operating expenses of $87.34M in Q1 2026.

What does other operating expenses mean?

Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Travel + LeisureTNL

$5M+150%

UnifirstUNF

$177K+233%

Syndax PharmaceuticalsSNDX

$99.07M-4.6%

KemperKMPR

$277M-5.9%

NelnetNNI

$233.99M+7.3%

Sabra HealthcareSBRA

-$55K-245%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$521.35M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's other operating expenses?: Eikon Therapeutics, Inc. (EIKN) reported other operating expenses of $87.34M in Q1 2026.
What does other operating expenses mean?: Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.